180 Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

180 Wealth Advisors, LLC

  • $789 Million
  • Q3 2025

A detailed history of 180 Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 16,437 shares of BMY stock, worth $713,201. This represents 0.09% of its overall portfolio holdings.

Number of Shares
16,437
Previous 16,015 2.64%
Holding current value
$713,201
Previous $741,000 -0.0%
% of portfolio
0.09%
Previous 0.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 16, 2025
BUY
$43.31 - $48.98 $18,276 - $20,669
422 Added 2.64%
16,437 $741,000
Q2 2025

Jul 30, 2025
SELL
$44.12 - $59.6 $103,196 - $139,404
-2,339 Reduced 12.74%
16,015 $741,000
Q1 2025

Apr 08, 2025
SELL
$53.9 - $63.11 $9,486 - $11,107
-176 Reduced 0.95%
18,354 $1.12 Million
Q4 2024

Jan 13, 2025
SELL
$51.92 - $59.94 $1,246 - $1,438
-24 Reduced 0.13%
18,530 $1.05 Million
Q3 2024

Oct 31, 2024
BUY
$39.66 - $51.75 $74,441 - $97,134
1,877 Added 11.26%
18,554 $960,000
Q2 2024

Jul 16, 2024
SELL
$40.25 - $52.99 $21,171 - $27,872
-526 Reduced 3.06%
16,677 $692,000
Q1 2024

Apr 15, 2024
SELL
$47.98 - $54.4 $84,540 - $95,852
-1,762 Reduced 9.29%
17,203 $932,000
Q4 2023

Jan 24, 2024
BUY
$48.48 - $57.85 $25,306 - $30,197
522 Added 2.83%
18,965 $973,000
Q3 2023

Oct 31, 2023
SELL
$57.89 - $64.73 $38,554 - $43,110
-666 Reduced 3.49%
18,443 $1.07 Million
Q2 2023

Jul 11, 2023
SELL
$63.71 - $70.74 $18,412 - $20,443
-289 Reduced 1.49%
19,109 $1.22 Million
Q1 2023

Apr 07, 2023
SELL
$65.71 - $74.53 $6,111 - $6,931
-93 Reduced 0.48%
19,398 $1.34 Million
Q4 2022

Feb 02, 2023
BUY
$68.48 - $81.09 $95,598 - $113,201
1,396 Added 7.71%
19,491 $1.4 Million
Q3 2022

Oct 12, 2022
SELL
$0.13 - $76.84 $272 - $161,133
-2,097 Reduced 10.39%
18,095 $1.29 Million
Q2 2022

Jul 11, 2022
SELL
$72.62 - $79.98 $158,093 - $174,116
-2,177 Reduced 9.73%
20,192 $1.55 Million
Q1 2022

Apr 22, 2022
SELL
$61.48 - $73.72 $45,433 - $54,479
-739 Reduced 3.2%
22,369 $1.71 Million
Q4 2021

Jan 26, 2022
SELL
$53.63 - $62.52 $14,211 - $16,567
-265 Reduced 1.13%
23,108 $1.47 Million
Q3 2021

Oct 28, 2021
BUY
$59.17 - $69.31 $32,898 - $38,536
556 Added 2.44%
23,373 $1.36 Million
Q2 2021

Aug 13, 2021
BUY
$61.91 - $67.42 $37,269 - $40,586
602 Added 2.71%
22,817 $1.54 Million
Q1 2021

May 25, 2021
BUY
$59.34 - $66.74 $51,981 - $58,464
876 Added 4.11%
22,215 $1.49 Million
Q4 2020

Jan 27, 2021
BUY
$57.74 - $65.43 $62,936 - $71,318
1,090 Added 5.38%
21,339 $1.42 Million
Q3 2020

Oct 23, 2020
BUY
$57.43 - $63.64 $24,235 - $26,856
422 Added 2.13%
20,249 $1.23 Million
Q2 2020

Jul 21, 2020
BUY
$54.82 - $64.09 $44,842 - $52,425
818 Added 4.3%
19,827 $1.2 Million
Q1 2020

Apr 09, 2020
BUY
$46.4 - $67.43 $102,590 - $149,087
2,211 Added 13.16%
19,009 $1.05 Million
Q4 2019

Jan 17, 2020
BUY
$49.21 - $64.19 $544,262 - $709,941
11,060 Added 192.75%
16,798 $1.12 Million
Q3 2019

Oct 22, 2019
BUY
$42.77 - $50.71 $2,138 - $2,535
50 Added 0.88%
5,738 $296,000
Q2 2019

Aug 05, 2019
SELL
$44.62 - $49.34 $65,189 - $72,085
-1,461 Reduced 20.44%
5,688 $257,000
Q1 2019

May 14, 2019
SELL
$45.12 - $53.8 $122,410 - $145,959
-2,713 Reduced 27.51%
7,149 $338,000
Q3 2018

Nov 14, 2018
BUY
$55.19 - $62.25 $71,636 - $80,800
1,298 Added 15.16%
9,862 $612,000
Q2 2018

Aug 08, 2018
BUY
$50.53 - $62.98 $113,490 - $141,453
2,246 Added 35.55%
8,564 $474,000
Q1 2018

Jun 01, 2018
BUY
$59.92 - $68.98 $34,513 - $39,732
576 Added 10.03%
6,318 $402,000
Q4 2017

Feb 13, 2018
BUY
$59.94 - $65.35 $344,175 - $375,239
5,742
5,742 $352,000

Others Institutions Holding BMY

# of Institutions
2,672
Shares Held
1.63B
Call Options Held
22.4M
Put Options Held
25.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $92.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track 180 Wealth Advisors, LLC Portfolio

Follow 180 Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email